TAGLN2 promotes papillary thyroid carcinoma invasion via the Rap1/PI3K/AKT axisLidong Wang, Zhen Liu, Yanxu Dong et al.|Endocrine Related Cancer|2022Cited by 19
MiR-613 inhibits the proliferation, migration, and invasion of papillary thyroid carcinoma cells by directly targeting TAGLN2Yonglian Huang, Zhen Liu, Hengwei Zhang et al.|Cancer Cell International|2021Cited by 14